Please assess the completion status of the following clinical trial:

Trial Title: Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* For MAIN period (NN5401-3590):~* Diagnosis of type 2 diabetes mellitus for at least 6 months~* Insulin naïve subjects~* Treatment with metformin and at least one other oral antidiabetic drug for at least 3 months before trial start~* Glycosylated haemoglobin (HbA1c) between 7.5 - 11.0% (both inclusive)~* Body Mass Index (BMI) no higher than 40.0 kg/m\^2~* For EXTENSION period (NN5401-3726):~* Informed consent obtained before any trial-related activities~* Must have completed the 26-week treatment period (visit 28) in trial NN5401-3590~Exclusion Criteria:~* For MAIN period (NN5401-3590):~* Treatment with glucagon like peptide-1 (GLP-1) receptor agonists and/or thiazolidinedione(s) within the last 3 months prior to trial start~* Cardiovascular disease diagnosed within 6 months before trial start~* For EXTENSION period (NN5401-3726):~* Anticipated change in concomitant medication known to interfere significantly with glucose metabolism, such as systemic corticosteroids, beta-blockers, Monoamine oxidase (MAO) inhibitors~* Anticipated significant lifestyle changes during the trial, e.g. shift work (including permanent night/evening shift workers), as well as highly variable eating habits as judged by the physician)~* Pregnancy, breast-feeding, the intention of becoming pregnant or not using adequate contraceptive measures according to local requirements

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- IDegAsp OD (Type: EXPERIMENTAL): None
- IGlar OD (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).